BIOFORCE NANOSCIENCES HOLDINGS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bioforce Nanosciences Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2017 to Q3 2024.
  • Bioforce Nanosciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$122K, a 7.41% decline year-over-year.
  • Bioforce Nanosciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$482K, a 1.99% decline year-over-year.
  • Bioforce Nanosciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$472K, a 2.79% increase from 2022.
  • Bioforce Nanosciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$486K, a 3.28% increase from 2021.
  • Bioforce Nanosciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$502K.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$482K -$122K -$8.42K -7.41% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$473K -$114K -$509 -0.45% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$473K -$131K -$808 -0.62% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 -$472K -$114K +$325 +0.28% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$472K -$114K +$8.98K +7.33% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$481K -$114K +$1.85K +1.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$483K -$130K +$2.4K +1.82% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 -$486K -$115K +$5.97K +4.94% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$491K -$123K -$8.73K -7.67% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$483K -$116K +$6.53K +5.34% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$489K -$132K +$12.7K +8.73% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$502K -$121K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$114K +$4.06K +3.45% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$122K +$4.4K +3.47% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 -$145K +$158M Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-05-05
Q3 2020 -$158M -$118K -$112K -1762% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$158M -$127K -$120K -1664% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-07-30
Q1 2020 -$158M -$158M* -$158M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-27
Q4 2019 -$46.5K -$20.2K -$11.6K -135% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-16
Q3 2019 -$35K -$6.33K +$309 +4.65% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 -$35.3K -$7.18K +$21.3K +74.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-22
Q1 2019 -$56.6K -$12.9K +$11.1K +46.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 -$67.7K -$8.59K Oct 1, 2018 Dec 31, 2018 10-K/A 2020-03-09
Q3 2018 -$6.64K -$4.44K -202% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$28.5K Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-22
Q1 2018 -$24K Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-30
Q3 2017 -$2.2K Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.